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The wolf at the door
SmIle thoughts on the biochemistry of the tubercle bacillus
M. R. w. EHLERS
It was coughing, obviously, a man coughing; but
coughing like to no other [he] had ever heard, and
compared with which any other had been a magnifi-
cent and healthy manifestation of life: a coughing
that had no conviction and gave no relief, that did
not even come out in paroxysms, but was just a fee-
ble, dreadful welling up of the juices of organic disso-
lution.
Thomas Mann, The Magic Mountain
M ycobaaen·um tuberculosis infects one-third of theworld's population. Every year 8 million newcases of tuberculosis are reported, with 3 mil-
lion deaths world-wide. Globally, it is the leading cause
of death from a single infectious agent, surpassing even
malaria. These grim statistics emerged from the recent
World Congress on Tuberculosis, held in Bethesda,
USA, on 16 - 19 November 1992. Even more sobering
is the fact that despite its discovery by Robert Koch
more than 100 years ago, the biochemistry and physio-
logy of M. ruberculosis are poorly understood in mole-
cular terms, as are the means by which it so successfully
enters and multiplies within its host cell, the macro-
phage.' Bluntly stated, the virulence determinants that
dramatically distinguish M. tuberculosis from its free-
living, saprophytic cousins are completely un~own.
Without fundamental advances in our understanding ill
these areas we are unlikely to develop effective therapeu-
tic regimens, which are becoming ever more urgent as
existing strategies are being blunted and even rendered
useless by the growing problem of dual M. tuberculosls/
HIV infections and emergent multi-drug-resistant tuber-
culosis (MDR-TB).
M. tuberculosis is a sinister organism. Although
descended from a family of saprophytes (organisms liv-
ing on dead or decaying organic matter)/ it is a faculta-
tive intracellular pathogen that effortlessly invades what
should be a hostile and aggressive host cell, the macro-
phage. This strategy appears to be central to the modus
operandi of M. tuberculosis since without effiCIent coloru-
sation of macrophages an infection cannot be estab-
lished; in this regard M. tuberculosis resembles other
facultative and obligate intracellular pathogens, such as
Leishmania, Toxoplasma gondii, Trypanosoma crUZI,
Legionella pneumophila and Bordetella pertussis. M<?reover,
in common with these organisms M. tuberculOSIS effec-
tively escapes macrophage killing mechanisms (espe-
cially human macrophages) and replicates i~tra­
cellularlyY The infectiousness of this pathogen IS so
great as to border on the bizarre, as there appears t<? be
no threshold of organisms required to produce infecuon:
in animal studies between 1 and 10 bacilli in airborne
droplet nuclei can cause infection.' Unusual also is the
remarkable capacity for donnancy (or latency) of tuber-
cle bacilli in old, walled-off primary foci: some investiga-
tors believe, although there are no hard data, that these
bacilli are never eradicated during the lifetime of the
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infected individual, even with no evidence of active
disease (the lifetime risk of developing active disease is
10%').
However, M. tuberculosis is not limited to an intracel-
lular environment. As infection progresses to active dis-
ease, bacilli burst out of macrophages and grow- extra-
cellularly within a solid, necrotic (caseous) lesion. If nor
contained, the caseous lesion can break into a bronchus
allowing formation of a large cavity, or the solid necrosis
liquefies, in either case creating a rich medium for the
extracellular proliferation of bacilli, which may reach
lO'/ml.' Thus the cunning and victorious intracellular
parasite remms to the practices of its saprophytic ances-
tors, feasting on dcad and decaying human tissu.es.
How, in molecular terms, are these propertIes to be
explained? It is difficult to reconcile the notion that the
tubercle bacillus is essentially inert - and that all the
marIifestations of tuberculosis are solely the result of the
host immune response - with the fact that there are
numerous strains within the M. tuberculosis complex -
and other closely related mycobacterial species - that
differ profoundly in the type and severity of disease
caused. It is more likely that there are strain- and
species-specific virulence factors that are central to the
pathogenicity of M. tuberculosis and to the process of
dormancy.
Over the years, a great deal of sigrtificance has been
attached to two peculiar characteristics of the tubercle
bacillus: its prodigiously thick and waxy cell wall, and its
slow growth.2 In this article a brief review is presented of
these characteristics and their sigrtificance. At the outset,
however it should be noted that despite intensive inves-
tigation fuese two hallmarks have not been consistently
linked to virulence; their role in dormancy is speculative.
The wall
On the face of it, the mycobacterial cell wall appears to
be unique among prokaryotes. Attention to it was drawn
early on by the unusual property of acid-fast staining,
which placed the mycobacteria outside of the broad
classification scheme based on Gram staining. Subse-
quent chemical analysis revealed it to contain an un-
usually high proportion of lipids - over 60% of the
weight of the cell wall - which, moreover, are of con-
siderable complexity! The mystique of the mycobac-
terial cell wall was further reinforced by the bewildering
intricacy evident on ultrastructural (electron micro-
scopy) analysis, which generated the impression that it
was unlike any other.' However, careful review of the
ultrastructural data by Draper" indicated that some of
this confusion was the result of technical artifacts and
that the cell wall structure was considerably simpler
than initially thought when it was appreciated that
essentially the mycobacterial envelope consists of three
components: the plasma membrane, the cell wall pr<?-
per, and an outer, loosely anached capsule; the latter ~s
highly variable depending on species and culture condi-
tions. Rigorous chemical dissection of the cell wall pro-
per has established that none of the core components IS
unique to mycobacteria, but that the sum of ItS pans
forms an entity that is unusual and characteristic for this
genus.,,7 Thus, the differences between the walls. of
mycobacteria and other prokaryotes are mostly quanuta-









Schematic representations of mycobacterial, Gram-posi-
tive and Gram-negative cell walls; not drawn to scale.
Ovals and rectangles depict sugar residues. Circles
represent the polar headgroups of phospholipids. Long
straight lines represent fatty acyl chains (mycolic acids
and membrane phospholipids). Note that the backbone
of the mycobacterial wall is based on peptidoglycan, as
is the case for almost all bacteria; in addition, it shares
features with both Gram-positive and Gram-negative
walls. In common with the former are: (I) polysaccharide
side-chains - arabinogalactan in mycobacteria, teichoic
acids in Gram-positives - linked to the peptidoglycan via
phosphodiester bonds between N-acetylglucosamine
and muramic acid (1-7 6Iinkage);s.,~ and (il) lipoarabino-
mannan (LAM), which is analogous to lipoteichoic acid
in that both are polysaccharides anchored in the cell
membrane via diacylglycerol units.··· In common with
Gram-negatives are: (I) presence of lipids external to
the peptidoglycan layer; and (iI) LAM, although analo-
gous to Iipoteichoic acid (see above), also resembles
lipopolysaccharide in physical and biological terms.'
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As is evidem from Fig. 1, the mycobacterial cell wall
skeleton consists of three covalentlv linked macro-
molecules, peptidoglycan, arabinogala~tan, and mycolic
acid. The peptidoglycan layer forms the backbone of the
cell wall skeleton, as is the case for virtually all bacteria
(Gram-positive and Gram-negative), differing only in
detail. Typically, peptidoglycans are composed of chains
of a polysaccharide - formed from alternating units of
glucosamine and muramic acid - cross-linked by
tetrapeptide side-chains.' The next layer is a complex
polysaccharide called arabinogalactan, which is cova-
lendy linked to muramic acid residues of the peptidogly-
can. The arabinogalactan consists of a homopolysaccha-
ride backbone of galactose units, from which chains of
arabinose units branch off.' A wide variety of other bac-
terial cell walls have side-chain polysaccharides attached
to the peptidoglycans, such as, for example, the teichoic
acid chains in Gram-positives' (see Fig. 1); in at least
two groups - corynebacteria and nocardias - the
polysaccharide is immunologically similar to the ara-
binogalactan of mycobacteria.'
The third layer of the cell wall skeleton consists of
mycolic acids, which are attached as esters to terminal
arabinose residues of arabinogalactan (Fig. 1). Mycolic
acids are known to be high-molecular-weight I)-hydroxy
fatty acids with a long a-side-chain (the terms a and I)
refer to the carbons adjacent to the carboxylate func-
tion). The main carbon (or alkyl) chain in each mycolic
acid contains 50 - 60 carbon atoms, whereas the a-
branched side-chain comains another 24 carbon atoms.
Considering that conventional fany acids in animals
comain between 16 and 20 carbons, the considerable
complexity of these lipids can be appreciated; also, these
carbon chain lengths transform the properties of mycolic
acids from those of fats or oils into those of waxes.
Indeed, it seems likely that the mycolic acids are pri-
marily responsible for producing a continuous outer
waxy coat in these organisms.5 Once again, though, it is
notable that these molecules are not unique to myco-
bacteria; they are also found in corynebacteria and
nocardias, albeit with shorter chain lengths. 6
In addition to the covalendy linked macromolecules
described above that together constitute the cell wall
skeleton, the M. tuberculosis cell wall contains consider-
able quantities of non-covalendy-associated glycolipids
and proteins. Of these, the most interesting glycolipid is
lipoarabinomannan (lAM, not to be confused with ara-
binogalactan discussed above). This moiety consists of a
polysaccharide, containing arabinose and mannose
units, covalendy linked to a phosphatidylinositol group
that anchors the molecule in the mycobacterial cell
membrane. The polysaccharide extends through the
peptidoglycan layer to the external side of the cell wall,
analogous to lipoteichoic acids of Gram-positive organ-
ismsY LAM has elicited considerable interest because it
has broad immunological activities analogous to
lipopolysaccharide (or endotoxin) of Gram-negative
rods! However, claims that it constitutes a primary viru-
lence factor for M. tuberculosis are difficult to accept in
light of the fact that lAM is found in all mycobacteria
irrespective of virulence.'
Other loosely bound, complex, free lipids and glyco-
lipids include trehalose-based glycolipids in which long-
chain fatty acids, including mycolic acids, are esterified
to the disaccharide trehalose (the dimycolyltrehaloses
are also called 'cord factor'); sulphated acyl trehaloses,
also called sulphatides; phenolic glycosides and peptido-
glycolipids (mycosides); and true waxes or cerides (e.g.
phenolic phthiocerol).' Most of these free wall-lipids are
exceedingly complex and many remain structurally
uncharacterised. These lipids are thought to interdigi-
tate with the structural mycolic acids covalently bound
to the arabinogalactan layer (Fig. 1) and contribute con-
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siderably to the exueme lipophilicity and waxiness of the
mycobacterial cell wall.
For the most part the identity and functions of wall-
associated proteins are unknown. Obscure also is how
they are anchored or, indeed, the route through the cell
wall for secreted proteins, which are abundant. lo If the
wall is uniformly dense and waxy, how do proteins
penetrate? These are not esoteric questions. There is a
growing awareness that the pathogenicity and virulence
of invasive micro-organisms is dependent in part on cell-
surface and secreted proteins that interact with host
tissues and cells, enabling these organisms to invade,
escape host defences, and replicate." To date, virulence-
determining cell-surface proteins analogous to, for
instance, invasin of Yersinia enterocolilica or gp63 of
Leishmania, have not been identified on M. lUberculosis.
However, the search for such proteins is warranted,
since despite intensive study none of the mycobacterial
cell wall glycolipids has been convincingly and consis-
tently linked to virulence.
In summary, the mycobacterial cell wall skeleton,
though distinctly unusual, cannot be considered to be
unique; rather, it differs only in detail from those of
other bacteria. The composition and functions of wall-
associated glycolipids and proteins are only partly
understood and no single component has yet been
demonstrated to be a primary virulence determinant in
M. luberculosis. It has been noted that the hydrophobic
mycobacterial envelope constitutes a sophisticated
barrier enabling survival under adverse conditions and
obviating the need for specialised survival- mechanisms
such as sporulation.' Thus, the mycobacterial wall may
play a central role in the maintenance of a long-lived
dormant state, postulated by many to be responsible for
latency and reactivation of tuberculosis.
The metabolism
The second characteristic of M. luberculosis that is dis-
tinctly unusual is its slow growth: the doubling time is in
the order of 12 - 20 hours, which is remarkably slow in
comparison with the 20 minutes of Escherichia coli. 12
However, whereas this is characteristic of members of
the M. lUberculosis complex and other species such as M.
aviumlintracellulare, M. scrojulaceum, and M. kansasii,
there are other mycobacteria - M. jOTlUilUm, M. che-
lonei, and M. smegmacis - with considerably faster
growth rates (doubling times of I - 2 hours) that
approach those of most bacteria. 13 Thus, slow growth is
not a defining characteristic of the entire genus, and
moreover it does not correlate with virulence: for
instance, whereas M. lUberculosis is a slow-growing
species, the virulent H37Rv strain is faster growing in
vivo in the mouse than the avirulent H37Ra strain;I' the
BCG strain of M. bovis is slow-growing but with mini-
mal pathogenicity; and M. jOTlUilUm is a fast-growing
opportunistic pathogen. AB frustrating as the inability to
link slow growth with virulence and pathogenicity has
been the failure, despite extensive study, to provide a
metabolic explanation for this phenomenon. 12,15
Arguments that anempt to explain slow growth on
the basis of substrate limitation imposed by the thick
lipoidal cell wall, or on the basis of the small number of
ribosomal RNA (rRNA) genes (rRNA is required for
protein synthesis) - M. luberculosis contains one rRNA
gene versus seven in E. coli - are not convincing in the
face of large variations of growth rates among myco-
bacterial species that share these propenies. 12 Further, it
has not been possible to distinguish between inherent
oddities of mycobacterial metabolism that can directly
account for the slow growth as opposed to low meta-
bolic activities that are a consequence of slow growth. It is
pertinent that no fundamental difference between the
metabolism of mycobacteria and other bacteria has yet
been uncovered.!2,15
The nutritional requirements of M. luberculosis are
simple and the organism can grow on minimal culture
media containing a simple source of organic carbon (e.g.
glycerol), inorganic nitrogen (NH./) , and the usual
inorganic elements and trace elements;!2 no particular
growth factor or vitamin is required. I' However, the
nutrition of M. luberculosis must be considerably dif-
ferent when it grows within host tissue, particularly
intracellularly, than when it is grO\vn in an in vilTO cul-
ture medium. It is likely to prefer to assimilate pre-
assembled molecules - amino, nucleic and fany acids,
etc. - in order to reduce its synthetic metabolic load
and thereby turn off (at the gene level) complex and
energy-expensive synthetic machinery, allowing it
instead to invest its metabolic energy in crucial virulence
determinants required for survival within hostile
macrophages. In this selling it is probable that M. tuber-
culosis is forced to compete with the metabolic processes
of the host cell for nutrients,!2 which may become limit-
ing with resultant starvation.
M. lUberculosis and mycobacteria in general appear to
be singularly well suited to surviving starvation.
Although they do not form spores, these organisms can
be maintained in distilled water for 2 years (and proba-
bly much longer) with no loss of viability.lo Curiously,
this treatment produces a complete loss of acid-fastness
and resistance to any form of staining (chromophobi-
city), which can be mimicked by chemical reduction,
and this has been interpreted to mean that starvation
results in a progressive shuning-off of oxidative meta-
bolism and the onset of dormancy.lo,17 Similar changes
appear in response to low oxygen tensions, and chromo-
phobic tubercle bacilli have reportedly been isolated
from chronic, caseous lesions. lo Taken together, these
data provide a picture of a highly adaptable organism,
one that grows in a metabolically active, acid-fast form
when conditions are favourable, and that can rapidly
switch to an inactive chromophobic state under adverse
conditions of starvation and hypoxia. These propenies
can explain how, after years and perhaps decades of dor-
mancy, tuberculosis can be endogenously reactivated.
It is conceivable that .M. luberculosis can never be com-
pletely eradicated by antimicrobial agents since dor-
mant, non-replicating organisms are not likely to be sus-
ceptible to such agents.
Although the biochemical basis for the slow growth
of M. luberculosis remains to be elucidated, a teleological
explanation for this phenomenon may be that the
organism is thereby constantly in a semi-hibernating
state with a minimal flow (or flux) through all metabolic
pathways and is therefore well placed to survive the sud-
den onset of starvation or hypoxia. This, coupled with
its unusually thick, waxy cell wall and facility for enter-
ing into a condition of profound dormancy, makes this
organism almost invincible, and it is no surprise that the
tubercle bacillus is one of the most formidable
pathogens in the long-suffering history of mankind.
The author is indebted to Colene Cywes and Lafras M.
Steyn for many thought-provoking discussions.
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Genito-urinary tuberculosis - experience with
52 urology inpatients
F. J. ALLEN, M. L. S. DE KOCK
Abstract The current trend in South African health services
is toward priInary care. Pubnonary tuberculosis is
well understood by the majority of priInary care
doctors and nurses, whereas genito-urinary tuber-
culosis may not be as easy to diagnose and treat.
We reviewed our experience with this condition
in 52 patients, who represented 0,74% of urology
adm.issions between 1986 and 1991. There was a 3:2
male/female ratio, the age range was 7-76 years
(mean 43 years), and the disease was more com-
mon among blacks and coloureds than among
whites. Multiple sites of involvement were fairly
common. Seventy-five per cent of patients had
renal involvement and 17% epididymal involve-
ment. The comm.onest presenting complaints were
urinary frequency and haematuria, although flank
and scrotal pain were also reported by a num.ber
of patients. Physical examination seldom helped
to suggest the diagnosis. On microscopic exami-
nation and culture of the urine, sterile pyuria was
present in only 50% of our patients and 29% had
positive cultures for a 'norm.al' coliform. organ-
ism. Fifty patients underwent excretory urography
and the findings were very varied. Patients were
treated priInarily with antituberculosis drugs, but
58% also required some form. of surgery; nephrec-
tomy was the commonest operation. Ureteral
strictures developed in over 50% of cases with
renal involvement.
We conclude that the diagnosis of genito-uri-
nary tuberculosis is not simple, and that treatment
must include regular follow-up at a specialist
institution.
S Air Med J 1993; 83: 903-907.
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e genito-urinary system is the leading site of
extrapulmonary tuberculosis. 1,2 In the First
World, about 8-10% of patients with pulmonary
tuberculosis will develop genito-urinary tuberculosis,
whereas in Third-World countries the incidence is
quoted as 15-20%.'
With the current emphasis on primary health care in
South Africa at the expense of the referral hospitals, we
felt it prudem to review our experience in order to eval-
uate whether primary care clinics are likely to be
equipped to diagnose and treat genito-urinary tubercu-
losis. Unlike pulmonary tuberculosis, genito-urinary
tuberculosis is not notifiable in South Africa; the actual
incidence is thus uncenain. We were therefore forced to
base this study only on patients who were admitted to
the urology wards at Tygerberg Hospital, where our
computer-based discharge data allowed such patients to
be identified. We reviewed our data from 1986 to 1991.
Patients and methods
From 1986 to 1991, all patients with a discharge diag-
nosis of genito-urinary tuberculosis were reviewed.
Involvement of the female genital system is excluded as
such patients, who most commonly present with infer-
tility, are seen by gynaecologists. In 10 patients there
were multiple sites of active tuberculosis but, when the
urinary system or male genital system was involved,
alone or as pan of more widespread disease, the patient
was diagnosed as having genito-urinary tuberculosis and
was managed by the Depanmem of Urology.
Some patiems were admitted more than once and in
4 patients there was insufficient evidence to confirm the
diagnosis; this left a patient population of 52 with con-
finned genito-urinary tuberculosis. In these patients all
available clinical, radiological and bacteriological data
were accessed and reviewed. The diagnosis was consid-
ered proven only on a positive culture of Mycobaaen·um
ruberculosis or typical histological findings, including
acid-fast organisms. Typical histology without identifi-
cation of organisms was considered 'diagnostic' (thus
allowing treaunent) in only 4 patiems.
